Related Experiment Video
Updated: May 10, 2026

Optimizing Tubulin Yield from Porcine Brain Tissue
Published on: October 11, 2024
Design, synthesis and biological studies of novel tubulin inhibitors
Yanjun Sun1, Bulbul Pandit, Somsundaram N Chettiar
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, 338 Parks Hall, 500 West 12th Avenue, Columbus, OH 43210-1291, United States.
Abstract:
A series of compounds originally derived from the vascular endothelial growth factor receptor tyrosine kinase inhibitor, SU5416, were synthesized and evaluated. The most potent compound in this series, compound 3, which structurally resembles the potent anti-microtubule agent combretastatin A-4, inhibited tubulin polymerization and showed potent growth inhibitory activities on both prostate and breast cancer lines with IC50 values in the low nanomolar range.
More Related Videos
07:54Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles
Published on: November 5, 2020
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Inhibitors of Bacterial DNA Synthesis
Destabilization of Microtubules
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Microtubule Formation